232 related articles for article (PubMed ID: 31065079)
1. High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice.
Li G; Zhang N; Geng F; Liu G; Liu B; Lei X; Li G; Chen X
Sci Rep; 2019 May; 9(1):7040. PubMed ID: 31065079
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: a metabolomics study.
Li N; Zhou L; Li W; Liu Y; Wang J; He P
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():54-61. PubMed ID: 25660715
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model.
Li F; Wu X; Li J; Niu Q
Mol Med Rep; 2016 Jun; 13(6):4904-10. PubMed ID: 27082952
[TBL] [Abstract][Full Text] [Related]
4. A UHPLC-TOF/MS method based metabonomic study of total ginsenosides effects on Alzheimer disease mouse model.
Gong Y; Liu Y; Zhou L; Di X; Li W; Li Q; Bi K
J Pharm Biomed Anal; 2015 Nov; 115():174-82. PubMed ID: 26210744
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of the effects of ginsenoside Re in an Alzheimer's disease mouse model.
Li J; Liu Y; Li W; Wang Z; Guo P; Li L; Li N
Behav Brain Res; 2018 Jan; 337():160-172. PubMed ID: 28927718
[TBL] [Abstract][Full Text] [Related]
6. A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease.
Li N; Liu Y; Li W; Zhou L; Li Q; Wang X; He P
J Ginseng Res; 2016 Jan; 40(1):9-17. PubMed ID: 26843817
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer's Disease.
Nie L; Xia J; Li H; Zhang Z; Yang Y; Huang X; He Z; Liu J; Yang X
Oxid Med Cell Longev; 2017; 2017():6473506. PubMed ID: 29204248
[TBL] [Abstract][Full Text] [Related]
8. Spatial metabolomics method to reveal differential metabolomes in microregions of Panax quinquefolius roots by using ultra-performance liquid chromatography quadrupole/time of flight-mass spectrometry and desorption electrospray ionization mass spectrometry imaging.
Luo S; Yang X; Zhang Y; Kuang T; Tang C
Food Chem; 2024 Mar; 435():137504. PubMed ID: 37813026
[TBL] [Abstract][Full Text] [Related]
9. Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease.
Zhang X; Wang J; Xing Y; Gong L; Li H; Wu Z; Li Y; Wang J; Wang Y; Dong L; Li S
Neuroscience; 2012 Sep; 220():191-200. PubMed ID: 22728092
[TBL] [Abstract][Full Text] [Related]
10. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
[No Abstract] [Full Text] [Related]
11. Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signalling transduction factors in the NG108-15 murine neuroglial cell line.
Zhao BS; Liu Y; Gao XY; Zhai HQ; Guo JY; Wang XY
Molecules; 2014 Oct; 19(10):16925-36. PubMed ID: 25340298
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease.
Wu JJ; Zhang L; Liu D; Xia J; Yang Y; Tang F; Chen L; Ao H; Peng C
J Ethnopharmacol; 2024 Jan; 318(Pt B):116955. PubMed ID: 37536646
[TBL] [Abstract][Full Text] [Related]
13. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model.
Fang F; Chen X; Huang T; Lue LF; Luddy JS; Yan SS
Biochim Biophys Acta; 2012 Feb; 1822(2):286-92. PubMed ID: 22015470
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and acetylcholine releasing effects of ginsenoside Rg1 in hippocampus of beta-amyloid model rats.
Liu Y; Gao Y; Li KX; Xue W
J Asian Nat Prod Res; 2019 Aug; 21(8):772-781. PubMed ID: 30501509
[TBL] [Abstract][Full Text] [Related]
18. Identifying quality-markers from Shengmai San protects against transgenic mouse model of Alzheimer's disease using chinmedomics approach.
Zhang AH; Yu JB; Sun H; Kong L; Wang XQ; Zhang QY; Wang XJ
Phytomedicine; 2018 Jun; 45():84-92. PubMed ID: 29685366
[TBL] [Abstract][Full Text] [Related]
19. New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease.
Wu JJ; Yang Y; Wan Y; Xia J; Xu JF; Zhang L; Liu D; Chen L; Tang F; Ao H; Peng C
Biomed Pharmacother; 2022 Aug; 152():113207. PubMed ID: 35667236
[TBL] [Abstract][Full Text] [Related]
20. [Effect of ginsenoside Rg1 on expressions of phosphory protein tau and N-methyl-D-aspartate receptor subunits NR1 and NR2B in rat brain slice model of Alzheimer's disease].
Li X; Liu Y; Zhang X; Yuan H; Quan Q
Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(24):3339-43. PubMed ID: 21438403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
